An Expert’s Guide To Switching In Germany, Part 2: Improving The Reclassification Process
Executive Summary
In Part 2 of this exclusive interview, Elmar Kroth, scientific director of the German Medicines Manufacturers´ Association, the BAH, tells HBW Insight what the association is doing to improve the prescription-to-OTC switch process in Germany.
You may also be interested in...
German Industry Wants To Simplify 'Complicated' Switch Process
The German Medicines Manufacturers´ Association
Use Real World Evidence To Drive Innovation, IQVIA Advises
Market researcher IQVIA explains how 'real world evidence' can help generate new health claims for OTC products and pre-market consumer data for innovative prescription-to-OTC switches.
An Expert’s Guide To Switching In Germany, Part 1: Navigating The Reclassification Process
Elmar Kroth, scientific director of the German Medicines Manufacturers´ Association, the BAH, talks exclusively to HBW Insight about prescription-to-OTC switching in Germany and the association’s efforts to improve this process.